Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with WWARN and in association with WHO an extensive review of antimalarial toxicity has been completed, focussing on DHA-piperaquine initially (and showing safety), and now extending to other antimalarial drugs.

The effects of malaria and fever on the ECG have been characterised and approaches for rate correction for the QT interval assessed based on the largest available databases.